Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells. Dr. Amany Keruakous sat down for an interview with CURE, in ...
CURE spoke with Dr. Surbhi Sidana about the recently approved antibody-drug conjugate Blenrep for multiple myeloma. On Oct. 23, it was announced that the U.S. Food and Drug Administration (FDA) ...
Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred ...
2don MSN
Immune system uses a conveyor belt-like process to edit defective antibodies, new research finds
The immune system's B cells create antibodies that can mount a response against just about anything—either destroying a ...
Patients with elevated anti-HLA antibodies experienced significantly prolonged time to transplant — a median of 120 days ...
A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets on cancer cells to induce cell death. “There is a power in seeing things,” ...
Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used ...
NEW YORK (Reuters) - While some potential vaccines have emerged in the global race to find a way to stop the spread of COVID-19, many scientists and researchers believe antibody based therapies hold ...
Antibody production can slow research to a crawl. As senior vice president of Biointron, Lei Shi works with scientists around the globe to optimize and expedite their antibody projects, from start to ...
Extracting meaningful insights from research is essential for scientific progress, whether it’s for discovering new medical treatments or better understanding complex biological systems. But as ...
Of the three, the AstraZeneca antibody combination Evusheld was most effective at inhibiting the ability of Omicron to infect cultured cells. Yet, the concentrations of the antibody combination that ...
A cocktail of antibodies could give us a new weapon to fight seasonal flu and new strains that cause pandemics. The mix protected mice from various strains of influenza, but hasn’t yet been tested in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results